Swedish Orphan Biovitrum AB (publ) KOL Haemophilia Call (Virtual) Transcript
Ladies and gentlemen, welcome to the Advanced under Standard of Care in Hemophilia Conference Call and Live Webcast. I am Alice, the Chorus Call operator. (Operator Instructions).
At this time, it's my pleasure to hand over to Guido Oelkers, Chief Executive Officer. Please go ahead, sir.
()-&
Thank you so much, and good afternoon, respectively, good morning to this event. Let's say, it's really a great pleasure to have you all with you the sequence of events after our last event on (inaudible) very excited about it. And maybe move to the next slide, which is a forward-looking statement as per usual. Today, I'm joined by Lydia Adad who is our acting Chief Medical Officer and who will be clinical efficacy and safety of efanesoctocog alfa. I'm really delighted also to have to welcome Dr. Robert Klamroth, who is Head of Internal Medicine at the hemophilia comprehensive care center, Vivantes in Berlin, Germany. And he is not only one of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |